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Objectives: To evaluate the association between visceral fat and cardiovascular risk factors and to
compare the ultrasonographic measurements of abdominal visceral fat with abdominal circum-
ference (AC).
Methods: This observational cross-sectional study categorized pubertal and postpubertal adoles-
cents into a control group (n ¼ 49) and an obese group (n ¼ 46). Weight, height, AC, blood pressure,
biochemical tests (lipid proﬁle, triacylglycerols, fasting glucose for insulinemia, and serum uric
acid), and ultrasound to measure visceral fat were assessed.
Results: We found signiﬁcant differences in the vascular risk variables between the groups, except
for total cholesterol and fasting blood glucose level. We also observed that 31 subjects in the
control group presented abnormalities in cardiovascular risk factors. The correlations between
abdominal visceral fat (measured by ultrasound or the AC) and cardiovascular risk factors were
signiﬁcant. In the entire sample, AC presented better sensitivity and speciﬁcity than the
ultrasound-measured abdominal visceral fat for identifying the presence of a cluster of at least
three cardiovascular risk factors (areas under the receiver operating characteristics curve 0.87 and
0.73, respectively).
Conclusion: Ultrasonographic measurements of visceral fat were correlated with cardiovascular risk
factors, but this association was also demonstrable with AC measurements. Our results suggest that
the measurement of visceral fat by ultrasound is unnecessary for the diagnosis of cardiovascular
risk in well-nourished or obese adolescents.
 2013 Elsevier Inc. Open access under the Elsevier OA license. Introduction
It is difﬁcult to estimate the global prevalence of overweight
and obesity in children and adolescents because the methods
used in the evaluation of these two conditions vary among
countries. In Brazil, studies carried out after the 1990s showed
an increase in overweight of 0.5% per year. [1] An analysis based
on four national Brazilian investigations (National Study on
Family Expenditures, 1974–1975; National Research on Health
and Nutrition, 1989; Research on Family Budget, 2002–
2003 and 2008–2009) showed a continuous increase in them Fundac¸~ao de Amparo a
ax: þ55-11-5539-1097.
gueira).
er OA license. prevalence of overweight and obesity. In adolescents, the
prevalence of overweight has tripled in the past 20 y, affecting
one-ﬁfth to one-third of all the young people who were
analyzed in the investigations. In the 34-y span from the
investigation in 1974 to 1975 until the more recent one in 2008
to 2009, the prevalence of overweight has increased by a factor
of 6 in boys (from 3.7% to 21.7%) and by a factor of almost 3 in
girls (from 7.6% to 19.4%) [2].
Obese adolescents are more likely to become obese adults
than normal-weight adolescents [3,4]. Studies have suggest that
the duration of obesity is directly associated with the morbidity
and mortality related to metabolic, cardiovascular, respiratory,
visceral, orthopedic, dermatologic, and neurologic factors and
with the morbidity and mortality related to hormonal abnor-
malities [5,6].
The excess of adipose tissue in obesity, and especially the
visceral adipose tissue (VAT), is associated with insulin resistance,
Table 1
Demographic data for the obese and control groups
Variable Obese Min–Max Control Min–Max P
(n ¼ 46) (n ¼ 49)
Age 15.5  1.5 12.6–19.1 16.2  1.3 14.0–19.9 0.01
Weight (kg) 94.6  19.4 64.4–170.8 59  8.7 40.7–79.9 <0.01
Height (cm) 167.6  8.7 149.5–191.0 167.6  8.7 150.2–201.5 0.98
BMI (kg/m2) 33.5  4.9 26.9–52.7 20.9  2.0 17.1–26.0 <0.01
BMI SDS 2.8  0.7 2.0–5.6 0.6  0.7 1.5 to 1.1 <0.01
Height SDS 0.4  0.9 1.5 to 3.0 0.0  1.0 1.7 to 4.1 0.08
BMI, body mass index; Max, maximum; Min, minimum, SDS, SD score
Values are presented as mean  SD
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and proinﬂammatory states [7]. During childhood and adoles-
cence, the amount of VAT represents less than 10% of total
abdominal fat, but it is known that the accumulation of VAT
increases with age [8].
The use of weight- and stature-based indicators in the anthro-
pometric evaluation of children is widespread, but to determine
a better diagnosis, it is interesting to associate information ob-
tained from other measurements and methods, such as physical
and laboratory examinations [9].
The methods used most often to measure total fat (e.g., the
body mass index [BMI]) do not predict the quantity of VAT [10].
Among the methods available to measure the quantity of VAT,
the use of anthropometric measurements (circumferences) is
widespread. These measurements, although at least in theory
not as accurate as the evaluation by imaging methods, are more
practical and have good reproducibility [10–12].
Although accurate and used as references in the evaluation of
the VAT, imaging methods such as computed tomography (CT)
and magnetic resonance imaging have the disadvantage of being
more expensive and exposing individuals to radiation [6,13].
Ultrasound (US) has been proposed as an alternative method for
the evaluation of visceral adiposity because it has a good corre-
lation with the results obtained by CT and is simpler, less
expensive, and free of radiation. Thus, it has been argued that the
US evaluation of VAT improves the diagnosis of visceral adiposity
[11,14].
Because obesity is an increasing public health concern in
adolescents, adequately treating excess weight and the meta-
bolic syndrome is fundamental to decrease the risk of cardio-
vascular complications [15]. The identiﬁcation of simple and
accurate low-cost methods showing a better correlation with
cardiovascular risk factors might play an important role in
reaching an early diagnosis of these problems. The objectives of
the present study were to 1) determine the association between
visceral fat and cardiovascular risk factors and 2) evaluate
comparatively the associations of visceral fat measurements by
abdominal US and abdominal circumference (AC) in their rela-
tion to a cluster of cardiovascular risk factors.
Materials and methods
We carried out a cross-sectional study in pubertal and postpubertal adoles-
cents. The Tanner sexual maturation stages IV and V were used for boys [16]; for
girls, the postpubertal stagewas deﬁned as 2.5 y after menarche. The participants
who took part in the study were selected by convenience among the patients
who came to medical appointments in the pediatric outpatient units at the
Federal University of S~ao Paulo and had not undergone suppressed nutritional
intervention previously. The study was approved by the university ethics and
research committee (0462/020).
The patients were normal weight or obese, according to the curves and
cutoffs from the Centers for Disease Control and Prevention [17]. Only patients
above the 95th percentile were considered obese. The following exclusion
criteria were adopted: 1) adolescents who presented with malnutrition, 2)
pregnant women, 3) patients using medication to control blood pressure, and 4)
patients who reported endocrine or neurologic disorders.
By convenience, we adopted a sample composed by 95 adolescents whowere
categorized into a control group (49 normal-weight adolescents, 25 boys and
24 girls) and an obese group (46 obese adolescents, 21 boys and 25 girls).
All the participants underwent evaluations of body weight (kilograms),
height (centimeters), blood pressure (millimeter of mercury), AC (centimeters),
and biochemical tests. Abdominal US was carried out to determine visceral and
subcutaneous fat amounts. The BMI was obtained using the following formula:
BMI ¼ weight (kilograms)/height (meters) squared. The values of BMI were
analyzed in percentiles and Z scores using Epi Info 3.5.3 (Atlanta, GA, USA).
The AC was measured with an inextensible measuring tape to an accuracy of
0.1 cm placed at themidpoint between the iliac crest and the last costal arch with
the subject in a standing position. The values were analyzed in percentiles, as
proposed by McCarthy et al. [18], and were considered cardiovascular riskscarriers in those adolescents no older than 17 y old whose AC was above the 90th
percentile [18]. For adolescents older than 17 y, we adopted the classiﬁcation
used for adults according to the National Institutes of Health [19].
The US technique described by Ribeiro-Filho et al. [11] was used to determine
the visceral fat based on a previous study performed in our institution by the
adult nephrology department [11]. In that study, visceral fat measured by US
showed a high correlation with CT-determined visceral fat (r ¼ 0.67, P < 0.0001).
The US method showed good reproducibility, with an intraobserver variation
coefﬁcient lower than 2%. In short, using a 3.5-MHz probe located 1 cm from the
umbilicus, the US measurement of intra-abdominal fat, deﬁned as the distance
from the internal face of the rectoabdominal muscle to the anterior wall of the
aorta, was performed [11].
Blood pressurewasmeasured three timeswith a semiautomatic oscillometric
monitor (Microlife, [Clearwater, FL, USA] model BP 3BTO-A; registered at the
National Agency of Sanitary Surveillance under no. 10222460029/0025 and the
U.S. Food and Drug Administration under no. 5164820186) at the time of
a volunteer’s recruitment, and the arithmeticmeanof the three valueswas used to
interpret the results [20].
All volunteers were asked to fast for 12 h before the tests, and evaluations of
serum fasting glucose, lipid proﬁle, triacylglycerols, and uric acid were carried out
by conventional methods. Fasting insulinemia was measured by immuno-
ﬂuorometric methods, and we adopted dosages lower than 15.0 mUI/mL as cutoff
values of normality [21]. Tests evaluated the subjects’ lipid proﬁle, including total
cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein choles-
terol, and triacylglycerols. The analysis of these results was based on the limits put
forth by the First Brazilian Guidelines for Prevention of Atherosclerosis in Child-
hood and Adolescence [21]. All tests were performed in all 95 subjects, except for
the serum uric acid dosage, which was executed in 94 adolescents.
Insulin resistance was evaluated using the homeostasis model assessment
(HOMA) developed by Turner et al. [22]. We used the value of 3.16 as the cutoff
for normality according to the First Brazilian Guidelines for Prevention of
Atherosclerosis in Childhood and Adolescence [21].
We classiﬁed the metabolic syndrome according to the deﬁnition provided
by the International Diabetes Federation [23] because it is speciﬁc to adolescents.
Moreover, the adolescents who presented a cluster of at least three cardiovas-
cular risk factors were considered as having a risk proﬁle.
To compare proportions between groups (obese versus control), we used the
chi-square test or the Fisher test. When we compared quantitative variables,
Student’s t test for independent samples was used. To evaluate the correlation
between the visceral fat measurements (US VAT and AC) and the cardiovascular
risk variables, we used the Spearman rank correlation. In all tests, a value of 5%
(a < 0.05) was used to reject the null hypothesis.
To estimate if US could be used to assess visceral obesity, we also performed
CT visceral fat measurements in a subgroup of ﬁve subjects from the control
group and the correlation coefﬁcient between US- and CT-measured visceral fat
was good (r ¼ 0.70).
To compare the sensitivity and speciﬁcity of visceral fat measurements (US
VAT and AC) for the identiﬁcation of the cluster of at least three cardiovascular
risk factors, we calculated the area under the receiver operating characteristics
curve for each mode of visceral fat measurement.
Results
The study sample included 95 adolescents; 49 were normal
weight and 46 were obese. The main demographic data of the
sample are listed in Table 1.
We found signiﬁcant differences in the cardiovascular risk
variables between groups, except for total cholesterol values and
fasting glucose, as presented in Table 2. Interestingly, we
observed that 31 subjects from the control group classiﬁed as
Table 2
Variables of cardiovascular risk in the obese and control groups
Variable Obese (n ¼ 46) Min–Max Control (n ¼ 49) Min–Max P
AC (cm) 102.8  12.2 86–153 74.4  6.3 61–91 <0.01
USVAT (cm) 3.4  1.5 1.3–8.0 2.3  0.9 0.9–4.3 <0.01
USSCT (cm) 3.3  0.9 1.7–5.1 1.1  0.7 0.2–3.1 <0.01
Triacylglycerols (mg/dL) 109.0  67.8 44–325 75.0  41.5 36–301 <0.01
Total cholesterol (mg/dL) 153.3  34.9 113–264 144.5  27.7 96–217 0.18
HDL cholesterol (mg/dL) 39.6  9.3 28–77 50.8  12.9 32–89 <0.01
LDL cholesterol (mg/dl) 92.0  28.2 52–173 79.6  21.1 44–129 0.02
Fasting glucose (mg/dL) 88.0  7.1 74–107 86.6  10.4 67–108 0.43
Insulinemia (mUI/mL) 16.9  10.2 3.8–47.8 7.9  3.3 2.4–17.3 <0.01
HOMA 3.7  2.3 0.8–10.3 1.7  0.8 0.6–3.8 <0.01
Serum uric acid (mg/dL) 6.2  1.4 3.6–9.6 5.2  1.5 2.4–10.1 <0.01
SBP (mmHg) 121.2  11.2 93–143 109.2  8.9 89–132 <0.01
DBP (mmHg) 70.5  7.4 60–88 63.6  8.3 47–88 <0.01
AC, abdominal circumference; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA, homeostasis model assessment; LDL, low-density lipoprotein; Max,
maximum; Min, minimum; SBP, systolic blood pressure; USSCT, ultrasound-measured subcutaneous tissue; USVAT, ultrasound-measured visceral abdominal tissue
Values are presented as mean  SD score
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least one cardiovascular risk factor (19 presented one factor,
11 presented two factors, and 1 presented four abnormalities):
triacylglycerols (n ¼ 5), total cholesterol (n ¼ 22), fasting glucose
(n ¼ 3), insulinemia (n ¼ 1), serum uric acid (n ¼ 2), low high-
density lipoprotein (n ¼ 20), and a high HOMA index (n ¼ 2).
Blood pressure was high in two subjects in this group.
When we analyzed the data by sex, most variables behaved
similarly to the total sample, except for fasting glucose, which
exhibited comparable values between obese and control subjects
in the total sample but signiﬁcant differences between groups in
girls only. In contrast, serum uric acid showed signiﬁcant differ-
ences in boys only (data not shown).
It is also worth noting that the classiﬁcation of AC in 13
normal-weight subjects indicated a risk for cardiovascular
diseases (boys, n ¼ 4; girls, n ¼ 9).
As presented in Table 3, the correlations between the fat
measurements and the cardiovascular risk indicators were
signiﬁcant and comparable, except for the correlations between
VAT and diastolic blood pressure and between VAT and low-
density lipoprotein cholesterol, which were not statistically
signiﬁcant. No signiﬁcant correlation was observed between
fasting glucose/total cholesterol and any of the fatty tissue
measurements we analyzed.
When we tested the AC and US VAT measurements for the
diagnosis of a cluster of at least three cardiovascular risk factors,
we observed that AC presented better sensitivity and speciﬁcityTable 3
Correlation coefﬁcients between AC, USVAT, and indicators of cardiovascular disease
AC USVAT
Correlation coefﬁcient P Correla
SBP 0.53 <0.01 0.41
DBP 0.39 <0.01 0.19
TG 0.39 <0.01 0.31
TC 0.17 0.10 0.09
HDL 0.50 <0.01 0.37
LDL 0.31 <0.01 0.16
Fasting glucose 0.00 0.96 0.1
Fasting insulinemia 0.58 <0.01 0.51
HOMA 0.55 <0.01 0.60
Uric acid 0.40 <0.01 0.33
AC, abdominal circumference; DBP, diastolic blood pressure; HDL, high-density lipopro
maximum;Min, minimum; SBP, systolic blood pressure; TC, total cholesterol; TG, triacy
measured visceral abdominal tissuethan US VAT for the entire sample (Table 4). After analyzing the
subgroups by sex, this difference was observed only in boys,
whereas AC and US VAT were comparable in girls.
Discussion
The clustering of cardiovascular risk factors in subjects from
the obese group stands out in the analysis of the present data,
emphasizing the known association of obesity with a higher
cardiovascular risk [24,25]. In childhood and adolescence, this
behavior is not different, and this phenomenon is all the more
worrying because of its early onset. In this regard, Berenson et al.
[26] highlighted that when metabolic changes are already
present in adolescence, the risk of developing cardiovascular
diseases increases over time [6,26].
Although obese adolescents on average showed more pro-
nounced changes in cardiovascular risk factors, an analysis of the
minimum and maximum values in the present data showed that
the subjects classiﬁed as having a normal weight by BMI also
showed changes in their metabolic proﬁle and blood pressure. In
this sample, 31 (63.3%) of the normal-weight subjects showed
some degree of change in their metabolic proﬁle or blood
pressure, and one subject was classiﬁed as having metabolic
syndrome. The BMI has been described as insufﬁcient to indicate
health risk and body fat accumulation, despite its widespread use
[6]. In 1981, Rudermanet al. [27] described theproﬁle of a normal-
weight, metabolically obese individual (“metabolically obese,”risk
USSCT
tion coefﬁcient P Correlation coefﬁcient P
<0.01 0.51 <0.01
0.06 0.39 <0.01
<0.01 0.22 0.04
0.41 0.14 0.18
<0.01 0.41 <0.01
0.12 0.28 <0.01
0.09 0.07 0.50
<0.01 0.50 <0.01
<0.01 0.47 <0.01
<0.01 0.31 0.02
tein; HOMA, homeostasis model assessment; LDL, low-density lipoprotein; Max,
lglycerol; USSCT, ultrasound-measured subcutaneous tissue; USVAT, ultrasound-
Table 4
Receiver operating characteristics curves for interaction of visceral fat
measurements and cluster of cardiovascular risk factors
Variables USVAT  Cluster* AC  Cluster*
Total (n ¼ 95) 0.73 (0.61–0.84) 0.87 (0.81–0.94)
Girls (n ¼ 49) 0.75 (0.57–0.93) 0.82 (0.70–0.95)
Boys (n ¼ 46) 0.68 (0.52–0.85) 0.92 (0.84–0.99)
AC, abdominal circumference; USVAT, ultrasound-measured visceral adipose
tissue
Data are presented as area under the curve (95% conﬁdence interval)
* Patients presenting a cluster of at least three cardiovascular risk factors.
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classiﬁcationwhononethelessdevelops complications associated
with obesity, such as hyperinsulinemia, hyperglycemia, and hy-
pertriglyceridemia. According to these investigators, these indi-
viduals may beneﬁt from a calorie-restricted diet or increased
physical activity because they display characteristics that are
similar to those of obese individuals, such as hyperinsulinemia
and an increase in adipocytes [27]. In agreement with our ﬁnd-
ings, Kelishadi et al. [28] found some adolescents who, although
classiﬁed as having a normal weight by BMI, displayed bio-
chemical abnormalities [28], and Li et al. [29] found hypergly-
cemia (0.7%), hypertriglyceridemia (17.5%), low high-density
lipoprotein (56.0%), and hypertension (14.3%) in normal-weight
adolescents.
In the present study, the measurement of fasting glucose was
not different among subjects from the two groups; this ﬁnding
was also seen by Carneiro et al. [3]. Weiss et al. [30] observed that
fasting glucose values above 100 mg/dL during adolescence are
rare. In the pediatric population, insulin resistance seems to
precede thedecrease in the function of b-cells in the development
of diabetes. It is well established that the pancreas, for a deter-
mined period, can adequately compensate for peripheral insulin
resistance by increasing the production of this hormone until the
capacity of these b-cells becomes insufﬁcient to produce insulin
and compensate for the degree of insulin resistance. As a conse-
quence, hyperglycemia emerges, changing a patient’s condition
from glucose intolerant to type 2 diabetic [31].
We also found signiﬁcantly higher values of insulin and
HOMA in the obese group, which suggests a high production of
insulin by pancreatic b-cells in these individuals and insulin
resistance. High values of fasting insulinemia and HOMA were
also found in other studies carried out in adolescents [32,33]. Sen
et al. [32] found a high prevalence of metabolic syndrome and
insulin resistance in obese adolescents. In a study of Brazilian
postpubertal obese adolescents, high values of fasting blood
glucose and HOMA were also found, with scores at 40.2% and
57.1%, respectively. In this same study, a correlation between
insulin resistance and the quantity of body fat (r ¼ 0.46) was
observed [33].
Since the 1980s, hyperuricemia has been described as
a marker of cardiovascular risk, regardless of the presence of
obesity [34]. Nonetheless, this criterion is not used very often as
a classiﬁcation factor for metabolic syndrome. The correlation
between hyperuricemia and visceral fat has been observed in
adults. Hikita et al. [35] found an association between a greater
concentration of serum uric acid and VAT dimension. In our
sample, we noticed an association between obesity and higher
levels of serum uric acid, and similar results were found in
children and adolescents with average age of 10 y in a study by
Paciﬁco et al. [36]. Japanese studies also have reported such an
association, and hyperuricemia was included as a criterion for
metabolic syndrome classiﬁcation [35,37,38].Subjects from the obese group in our sample showed higher
values for blood pressure than normal-weight subjects, and we
found a positive correlation between fat measurements (AC and
US VAT) and blood pressure, except for diastolic blood pressure.
These ﬁndings are in agreement with other studies in adoles-
cents in which a correlation between body weight and systolic
blood pressure was observed [4,39].
The association between visceral fat and cardiovascular risk
factor markers has been described very well in the literature
[11,24]. In 2001, Ribeiro-Filho et al. [11] reported the correlation
of US measurements of visceral fat to cardiovascular disease
risks. In their study in adults, these investigators reported that
the cardiovascular risk markers used to classify metabolic
syndrome were signiﬁcantly correlated with the VAT measure-
ment. Similarly, in their study in adults, Leite et al. [40] observed
that the VAT measurement has greater sensitivity and speciﬁcity
in identifying individuals with cardiovascular risk factors
compared with the AC, mainly in individuals classiﬁed as having
a moderate to high risk of developing cardiovascular diseases.
In our study, the US measurement of VAT was correlated with
most parameters formetabolic syndrome. As amethod, however,
the simple AC measurement was comparable to the US VAT
measurement, and the coefﬁcients of correlation of the AC with
most variables studied were higher than those obtained by VAT
measurement by US. The quantity of VAT seems to increase with
age [8], and the role of the USmeasurement of VAT in identifying
individuals with a higher cardiovascular risk may not be the
same for adolescents and adults.
Conversely, when using the AC, it is important to standardize
the evaluation points and to adopt the correct technique. In
a review written in 2003, Wang et al. [41] found 14 different
points for obtaining this measurement, which makes the clas-
siﬁcation of individuals all the more difﬁcult. In our practical
experience, we observed that the measurement of the AC in
obese adolescents, in addition to being observer dependent, is
difﬁcult to perform owing to the excessive amount of adipose
tissue in the central area and the shyness exhibited by some
individuals when exposed to this kind of measurement.
Central obesity has been described as the main factor of the
metabolic complications that cause cardiovascular diseases [26],
and in many consensus protocols and groups, it has been used as
a factor to classify metabolic syndrome [23,42]. The VAT is
known as the most metabolically active factor and the factor
with the strongest relation to metabolic syndrome [43]. In our
sample, the US VAT and the AC showed a signiﬁcant correlation
with most metabolic parameters analyzed, which suggests that
these two techniques are plausible methods for assessing the
association of central obesity with cardiovascular disease risk
factors.
Reinehr andWunsch [24] compared VAT US and AC measure-
mentswith biochemicalmarkers of cardiovascular disease risks in
89 obese children and adolescents 6 to 18 y old and found coefﬁ-
cients of signiﬁcant correlations onlywith theAC [24]. Conversely,
in a study of a sample comprised of 30 obese children at least 6 y
old, all were in the ﬁrst pubertal stage of the Tanner classiﬁcation,
Reyes et al. [12] found a better correlation of VAT measurements
by abdominal US with insulin, HOMA, and triacylglycerols
compared with the AC. However, when correlated with the crite-
rion for metabolic syndrome, the two measurements showed
signiﬁcant correlations [12]. It is important to note that in the
study by Reyes et al. the AC measurements were performed over
the umbilical scar, thus differing from our study. The differences
between the study by Reyes et al. and the present study (sample
size, AC measurement location, and average age) may justify the
H. Seibert et al. / Nutrition 29 (2013) 393–398 397different results obtained by these studies despite the similar
goals.
When we evaluated the sensitivity and speciﬁcity of the AC
andUSVATwith regard to the clusterof cardiovascular risk factors
by sex, the AC showed better sensitivity and speciﬁcity for indi-
cating cardiovascular risk in the male group. In contrast, the two
methodswere comparable in indicating cardiovascular risk in the
female group. This may have occurred as a result of pubertal
differences because some adolescents may be in a pubertal stage
longer than others and because of the differences in fat distribu-
tion in the body caused by hormonal differences. A review of
differences inbodycompositionbetweenboys andgirls according
to sexual maturation has indicated that hormonal differences
between genders cause the development of the muscle tissue in
boys to surpass the concentration of adipose tissue differently
from in girls, inwhom the amount of adipose tissue is larger [44].
Our study has methodologic constraints and these should
be pondered when considering the results. Our sample was
selected by convenience, thus our results are more susceptible to
the effect of selection bias. Moreover, the small sample does not
allow us tomake more elaborate inferences about this important
problem for the general population because the statistical power
to show subtle differences is restricted in a study sample of 95
subjects. Also, our study involved exclusively Brazilian adoles-
cents, so our results may not be applicable to other populations
because the genotypic distribution appears to differ among races.
In performing a cross-over study, we have provided merely
a picture of the risk factors that are clustered in a patient, but we
do not have any information about the actual cardiovascular
outcomes. Nevertheless, we hope the present study serves as
a tool for elaborating questions for future researches, and it is not
intended to be a set of deﬁnitive answers. The presence of
a control group allowed the establishment of clear gradients
of contrast of the cardiovascular risk factors associated with
obesity, and this is an aspect of the present study that seems
positive to us.
In short, this study supports the clustering of cardiovascular
risk factors in obese adolescents. Moreover, our ﬁndings suggest
that an evaluation by US is not superior to the AC measurement
to assess the risks related to obesity. This ﬁnding is important for
future studies for possibly decreasing costs and simplifying
research projects. For the medical practice, it strengthens the
notion that the AC measurement should be incorporated in the
anthropometric evaluation of pediatric patients.References
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